ABSTRACT Objective To describe the use of subconjuctival administration of the anti-tumor necrosis factor agent adalimumab for treatment of dry eye in patients with Sjögren’s syndrome, and to invest

NIAID Data Ecosystem30

Analysis of intraocular pressure variation after intravitreal injection of ranibizumab

眼内压监测

抗VEGF药物治疗评估

Abstract Objective: Treatment with anti-angiogenic drugs is one of the most widely used modalities of treatment of macular edema related conditions. Intravitreal injection of a VEGF-A inhibitor is h

NIAID Data Ecosystem20

Reference standard RCTs identified and RCTS identified by author as controlled trial by year of presentation at ARVO.

眼科临床试验

临床试验注册

*Box checked “Yes” for “human clinical trial” (n = 634).†Box checked “Yes” for “human controlled clinical trial” (n = 941).‡Information recorded in trial registration box (n = 797).§Does not include 5

Figshare2015-12-02 更新50

SWAN trial: Key ocular eligibility criteria for the study eye.

眼科临床试验

疾病诊断标准

SWAN trial: Key ocular eligibility criteria for the study eye.

Figshare2024-10-10 更新20